vs
Side-by-side financial comparison of Fidelity National Information Services (FIS) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
Fidelity National Information Services is the larger business by last-quarter revenue ($2.8B vs $1.5B, roughly 1.9× BeOne Medicines Ltd.). Fidelity National Information Services runs the higher net margin — 18.2% vs 4.4%, a 13.7% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 8.1%). Fidelity National Information Services produced more free cash flow last quarter ($739.0M vs $379.8M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 6.8%).
Fidelity National Information Services, Inc. (FIS) is an American multinational corporation which offers a wide range of financial products and services. FIS is most known for its development of Financial Technology, or FinTech. Annually, FIS facilitates the movement of roughly US$9 trillion through the processing of approximately 75 billion transactions in service to more than 20,000 clients around the globe.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
FIS vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $2.8B | $1.5B |
| Net Profit | $511.0M | $66.5M |
| Gross Margin | 38.3% | 90.5% |
| Operating Margin | 18.8% | 12.4% |
| Net Margin | 18.2% | 4.4% |
| Revenue YoY | 8.1% | 32.8% |
| Net Profit YoY | 97.3% | 143.8% |
| EPS (diluted) | $0.98 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.8B | $1.5B | ||
| Q3 25 | $2.7B | $1.4B | ||
| Q2 25 | $2.6B | $1.3B | ||
| Q1 25 | $2.5B | $1.1B | ||
| Q4 24 | $2.6B | $1.1B | ||
| Q3 24 | $2.6B | $1.0B | ||
| Q2 24 | $2.5B | $929.2M | ||
| Q1 24 | $2.5B | $751.7M |
| Q4 25 | $511.0M | $66.5M | ||
| Q3 25 | $264.0M | $124.8M | ||
| Q2 25 | $-470.0M | $94.3M | ||
| Q1 25 | $77.0M | $1.3M | ||
| Q4 24 | $259.0M | $-151.9M | ||
| Q3 24 | $224.0M | $-121.3M | ||
| Q2 24 | $243.0M | $-120.4M | ||
| Q1 24 | $724.0M | $-251.2M |
| Q4 25 | 38.3% | 90.5% | ||
| Q3 25 | 37.8% | 86.1% | ||
| Q2 25 | 36.4% | 87.5% | ||
| Q1 25 | 34.7% | 85.2% | ||
| Q4 24 | 36.9% | 85.8% | ||
| Q3 24 | 38.0% | 83.0% | ||
| Q2 24 | 38.2% | 85.1% | ||
| Q1 24 | 37.1% | 83.4% |
| Q4 25 | 18.8% | 12.4% | ||
| Q3 25 | 16.8% | 11.5% | ||
| Q2 25 | 15.6% | 6.7% | ||
| Q1 25 | 13.7% | 1.0% | ||
| Q4 24 | 18.5% | -7.0% | ||
| Q3 24 | 19.1% | -12.0% | ||
| Q2 24 | 15.2% | -11.5% | ||
| Q1 24 | 14.6% | -34.8% |
| Q4 25 | 18.2% | 4.4% | ||
| Q3 25 | 9.7% | 8.8% | ||
| Q2 25 | -18.0% | 7.2% | ||
| Q1 25 | 3.0% | 0.1% | ||
| Q4 24 | 10.0% | -13.5% | ||
| Q3 24 | 8.7% | -12.1% | ||
| Q2 24 | 9.8% | -13.0% | ||
| Q1 24 | 29.3% | -33.4% |
| Q4 25 | $0.98 | $0.05 | ||
| Q3 25 | $0.50 | $0.08 | ||
| Q2 25 | $-0.90 | $0.06 | ||
| Q1 25 | $0.15 | $0.00 | ||
| Q4 24 | $0.51 | $-0.10 | ||
| Q3 24 | $0.41 | $-0.09 | ||
| Q2 24 | $0.44 | $-0.09 | ||
| Q1 24 | $1.25 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $599.0M | $4.5B |
| Total DebtLower is stronger | $9.1B | $836.4M |
| Stockholders' EquityBook value | $13.9B | $4.4B |
| Total Assets | $33.5B | $8.2B |
| Debt / EquityLower = less leverage | 0.65× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $599.0M | $4.5B | ||
| Q3 25 | $571.0M | $4.0B | ||
| Q2 25 | $581.0M | $2.8B | ||
| Q1 25 | $805.0M | $2.5B | ||
| Q4 24 | $834.0M | $2.6B | ||
| Q3 24 | $1.3B | $2.7B | ||
| Q2 24 | $2.1B | $2.6B | ||
| Q1 24 | $3.3B | $2.8B |
| Q4 25 | $9.1B | $836.4M | ||
| Q3 25 | $8.9B | — | ||
| Q2 25 | $8.9B | — | ||
| Q1 25 | $8.7B | — | ||
| Q4 24 | $9.7B | — | ||
| Q3 24 | $10.5B | — | ||
| Q2 24 | $10.6B | — | ||
| Q1 24 | $10.6B | — |
| Q4 25 | $13.9B | $4.4B | ||
| Q3 25 | $13.9B | $4.1B | ||
| Q2 25 | $14.2B | $3.8B | ||
| Q1 25 | $15.1B | $3.5B | ||
| Q4 24 | $15.7B | $3.3B | ||
| Q3 24 | $16.6B | $3.4B | ||
| Q2 24 | $17.0B | $3.4B | ||
| Q1 24 | $18.0B | $3.4B |
| Q4 25 | $33.5B | $8.2B | ||
| Q3 25 | $33.0B | $7.6B | ||
| Q2 25 | $33.4B | $6.3B | ||
| Q1 25 | $32.8B | $5.8B | ||
| Q4 24 | $33.8B | $5.9B | ||
| Q3 24 | $34.3B | $5.8B | ||
| Q2 24 | $34.6B | $5.7B | ||
| Q1 24 | $35.9B | $5.7B |
| Q4 25 | 0.65× | 0.19× | ||
| Q3 25 | 0.64× | — | ||
| Q2 25 | 0.63× | — | ||
| Q1 25 | 0.57× | — | ||
| Q4 24 | 0.62× | — | ||
| Q3 24 | 0.63× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.59× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $758.0M | $417.3M |
| Free Cash FlowOCF − Capex | $739.0M | $379.8M |
| FCF MarginFCF / Revenue | 26.3% | 25.4% |
| Capex IntensityCapex / Revenue | 0.7% | 2.5% |
| Cash ConversionOCF / Net Profit | 1.48× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $2.5B | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $758.0M | $417.3M | ||
| Q3 25 | $1.0B | $402.6M | ||
| Q2 25 | $382.0M | $263.6M | ||
| Q1 25 | $457.0M | $44.1M | ||
| Q4 24 | $782.0M | $75.2M | ||
| Q3 24 | $641.0M | $188.4M | ||
| Q2 24 | $546.0M | $-95.6M | ||
| Q1 24 | $206.0M | $-308.6M |
| Q4 25 | $739.0M | $379.8M | ||
| Q3 25 | $952.0M | $354.5M | ||
| Q2 25 | $343.0M | $219.8M | ||
| Q1 25 | $420.0M | $-12.3M | ||
| Q4 24 | $764.0M | $-17.3M | ||
| Q3 24 | $605.0M | $54.7M | ||
| Q2 24 | $530.0M | $-205.5M | ||
| Q1 24 | $179.0M | $-465.1M |
| Q4 25 | 26.3% | 25.4% | ||
| Q3 25 | 35.0% | 25.1% | ||
| Q2 25 | 13.1% | 16.7% | ||
| Q1 25 | 16.6% | -1.1% | ||
| Q4 24 | 29.4% | -1.5% | ||
| Q3 24 | 23.5% | 5.5% | ||
| Q2 24 | 21.3% | -22.1% | ||
| Q1 24 | 7.3% | -61.9% |
| Q4 25 | 0.7% | 2.5% | ||
| Q3 25 | 2.2% | 3.4% | ||
| Q2 25 | 1.5% | 3.3% | ||
| Q1 25 | 1.5% | 5.0% | ||
| Q4 24 | 0.7% | 8.2% | ||
| Q3 24 | 1.4% | 13.3% | ||
| Q2 24 | 0.6% | 11.8% | ||
| Q1 24 | 1.1% | 20.8% |
| Q4 25 | 1.48× | 6.28× | ||
| Q3 25 | 3.83× | 3.22× | ||
| Q2 25 | — | 2.79× | ||
| Q1 25 | 5.94× | 34.71× | ||
| Q4 24 | 3.02× | — | ||
| Q3 24 | 2.86× | — | ||
| Q2 24 | 2.25× | — | ||
| Q1 24 | 0.28× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FIS
| Banking Solutions | $1.6B | 57% |
| Other | $701.0M | 25% |
| Capital Market Solutions | $508.0M | 18% |
ONC
Segment breakdown not available.